Squarepoint
VCYT icon

Squarepoint’s Veracyte VCYT Stock Holding History

Squarepoint’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,800
Closed -$1.14M – 5466
2024
Q4 		$1.14M Buy
+28,800
New +$1.09M ﹤0.01% 2941

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Squarepoint's VCYT Position: Q2 2026 in Review

Squarepoint reduced its Veracyte (VCYT) stake by 77% in Q2 2026, selling an estimated $2.07M and leaving 14,853 shares worth $872K. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Squarepoint first reported a position in VCYT in Q1 2017 and has held it in 30 quarters since. The position peaked at $24.3M in Q2 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Squarepoint held 14,853 shares of Veracyte worth $872K as of Q2 2026.
  • Squarepoint sold 49,301 Veracyte shares in Q2 2026, an estimated $2.07M.
  • Veracyte made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3008 holding.
  • Squarepoint first reported a position in Veracyte in Q1 2017 and has held it in 30 quarters since.
  • Squarepoint's Veracyte position peaked at $24.3M in Q2 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.